Faizan Farooque

Faizan Farooque

InvestorPlace Contributor

Expertise: Real estate investment trusts (REITs), SPACs, Cryptocurrencies

Education: BSc (Hons) Degree in Applied Accounting, Oxford Brookes University; Introduction to Data Analysis Using Excel, Rice University; Excel Skills for Business: Intermediate, Macquarie University

About Faizan
Faizan Farooque is a finance journalist who has reported on the latest trends in the stock market for many years. He helps people by providing advice about saving and investing and keeping up with what’s happening in the financial world.

Faizan is writing for InvestorPlace.com, GuruFocus, and TipRanks and has previously worked as a financial journalist and data analyst for S&P Global. He can analyze company filings from sources like SEC, FINRA, and others to help identify potential investment opportunities. Researching specific industries is also something he does to provide industry insight for clients.

Faizan deeply understands the market and how to read the financial tea leaves to anticipate where things are headed. His expertise gives readers an insider’s perspective on what’s happening in the finance world so they can make smart decisions.

Recent Articles

Until It Can Prove Itself, Riot Blockchain Is Still a Day Trade

By Faizan Farooque, InvestorPlace Contributor

There are relatively few ways to play crypto-mining stocks. So, RIOT stock will continue to gain steam despite a questionable past.

7 Robinhood Stocks Even Billionaires Want in Their Portfolios

By Faizan Farooque, InvestorPlace Contributor

Value investors tend to avoid Robinhood stocks; however, several companies on this list are solid performers worth a place in your portfolio.

Keep Buying Palantir Stock at These Reduced Levels

By Faizan Farooque, InvestorPlace Contributor

PLTR stock will continue to do well as the relationship between the controversial data-mining firm and the defense establishment deepens.

Jaguar Health Has Enough Short-Term Catalysts To Make It Interesting

By Faizan Farooque, InvestorPlace Contributor

It's easy to dismiss JAGX stock as just another beneficiary of the equity bull market. However, Jaguar Health has made significant strides during the last year.

The Boom Cycle for Churchill Capital Corp IV Is Over, But Short-Term Catalysts Remain

By Faizan Farooque, InvestorPlace Contributor

Investing in CCIV stock will only get you a 16% stake in Lucid, but the shares have short-term catalysts for retail traders to play .

Load More